Back to Search
MAHESH MANSUKHANI, M.D.
M.D.
Molecular Genetic Pathology (Pathology) Physician
NPI: 1477692556IndividualAccepts Medicare
Specialties, Licenses & Credentials
Molecular Genetic Pathology (Pathology) PhysicianPrimary
Pathology — Molecular Genetic Pathology
Code: 207ZP0007X
222689(NY)222689-1(NY)
CMS Specialties
PrimaryPATHOLOGY
Education
OTHER
Class of 1985
Research & Publications (20)
Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.
PMID 19681120·Genes Chromosomes Cancer·2009
8-other
Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors.
PMID 19499546·Int J Cancer·2009
8-other
Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study.
PMID 19525927·Mod Pathol·2009
8-other
Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
PMID 19273703·J Clin Oncol·2009
4-observational
Mutations in p53, p53 protein overexpression and breast cancer survival.
PMID 19602056·J Cell Mol Med·2009
8-other
KHSV(-) EBV(-) post-transplant effusion lymphoma with plasmablastic features: variant of primary effusion lymphoma?
PMID 19337983·Hematol Oncol·2009
5-case
Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha.
PMID 18559093·Mol Cancer·2008
4-observational
Prenatal diagnosis of congenital lipoid adrenal hyperplasia (CLAH) by estriol amniotic fluid analysis and molecular genetic testing.
PMID 18058976·Prenat Diagn·2008
5-case
PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer.
PMID 18408767·Oncogene·2008
7-preclinical
Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology.
PMID 18457340·Hematol Oncol·2008
8-other
Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression.
PMID 18506748·Genes Chromosomes Cancer·2008
8-other
Changes in prognostic significance and predictive accuracy of Gleason grading system throughout PSA era: impact of grade migration in prostate cancer.
PMID 17707892·Urology·2007
4-observational
Intermediate-risk localized prostate cancer in the PSA era: radiotherapeutic alternatives.
PMID 17382161·Urology·2007
4-observational
Phase II study of neoadjuvant androgen deprivation followed by external-beam radiotherapy with 9 months of androgen deprivation for intermediate- to high-risk localized prostate cancer.
PMID 17194907·J Clin Oncol·2007
3-trial
Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma.
PMID 17210525·Am J Clin Pathol·2007
8-other
Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes.
PMID 17243165·Genes Chromosomes Cancer·2007
8-other
Evaluation of surgical energy devices for vessel sealing and peripheral energy spread in a porcine model.
PMID 17945280·J Urol·2007
4-observational
Identification of rare Epstein-Barr virus infected memory B cells and plasma cells in non-monomorphic post-transplant lymphoproliferative disorders and the signature of viral signaling.
PMID 17018379·Haematologica·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 622 W 168TH ST, PATHOLOGY ADMINISTRATION PH1564W
NEW YORK, NY 10032 - Phone
- (212) 305-2646
Quick Facts
- NPI
- 1477692556
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile